Note: The job is a remote job and is open to candidates in USA. Avant Health is a clinical research organization and strategy consulting firm specializing in clinical and observational research. The company is seeking a Clinical Scientist to lead the scientific design and authoring of complex international Phase III and Phase IV clinical trial protocols, collaborate with statistical and research teams, assess operational feasibility, and support regulatory submissions and Clinical Study Reports.
Responsibilities
- Late-Stage Protocol Authoring: Lead the development and writing of high-quality Phase III/IV trial protocols, major amendments, Case Report Forms, and informed consent documents
- Therapeutic Architecture: Apply scientific expertise across multi-indication pipelines—specifically managing the unique nuances of oncology endpoints, immunology pathways, dermatological scoring indexes, and rare disease small-population constraints
- Cross-Functional Translation: Act as the primary scientific bridge between multiple research functions and lead trial designs and ensure they are scientifically rigorous, mathematically sound, and operationally viable
- Statistical Collaboration: Apply a strong understanding of late-stage biostatistical concepts (e.g., survival analysis, non-inferiority designs, power analysis, and endpoint validation structures) to collaborate directly on the Statistical Analysis Plan (SAP)
- Operational Feasibility: Review trial designs through an operational lens to ensure protocols minimize site burden, maximize patient retention, and scale effectively across global, multi-center late-phase frameworks
- Regulatory & Data Synthesis: Synthesize complex data to support major global regulatory submissions (FDA, EMA, health authorities) and contribute directly to the writing of comprehensive Clinical Study Reports
Skills
- Advanced scientific degree required ( Ph.D., Pharm.D., M.D., or Master's in Life Sciences/Public Health with equivalent extensive experience)
- 5+ years of direct experience in clinical research within a CRO setting, with a proven track record of authoring (hands-on) successful Phase III or IV trial protocols
- Demonstrated experience working in at least one (ideally multiple) of our core areas: Dermatology, Oncology, Immunology, or Rare Diseases
- Strong conceptual foundation in biostatistics
- The ability to interpret, critique, and direct statistical strategy is required
- Deep understanding of Good Clinical Practice (GCP), ICH guidelines, global regulatory pathways, and the practicalities of large-scale international site management
- Must be based in the US and capable of working autonomously in a remote, cross-border team environment
- Individuals located in Europe may be considered
- Direct hands-on programming experience in statistical software like SAS or R
Benefits
- Remote, cross-border team environment
Company Overview